ROBERTA HELLMAN: Open Payments
NPI 1992893143 · ARVERNE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,237 in 61 payments from 5 companies in 2025. Trend: 2023 $810 · 2024 $751 · 2025 $1,237
Food & beverage: $1,237
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 30 | $629 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $267 |
| Alkermes, Inc. | 10 | $216 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
Products named: INGREZZA, TRINTELLIX, ARISTADA, REXULTI, COBENFY, LYBALVI.
Industry payments across NY — which companies pay providers there.
